A Multi-center, Prospective, Registry Study to Estimate the Current Status of Care for Patients With Coronary Artery Disease
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Coronary Artery Disease
- Sponsor
- Beijing Anzhen Hospital
- Enrollment
- 100000
- Locations
- 1
- Primary Endpoint
- The overall composite of 10 performance measures for CAD care
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
The study will estimate the current status of care for participants with coronary artery disease
Investigators
Shao-Ping Nie
Principal Investigator
Beijing Anzhen Hospital
Eligibility Criteria
Inclusion Criteria
- •Hospitalized patients with discharge diagnosis as coronary artery disease (including atherosclerosis or non-athrosclerosis)
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
The overall composite of 10 performance measures for CAD care
Time Frame: Duration of hospital stay, an expected average of 1 week
Performance measures for CAD care including: Proportion of patients received fibrinolytic therapy within 30 mins (STEMI) Proportion of patients received primary percutaneous coronary intervention within 90 mins (STEMI) Proportion of patients received reperfusion therapy (STEMI, high or moderate risk NSTE-ACS) Proportion of patients with aspirin prescribed at discharge Proportion of patients with P2Y12 inhibitors prescribed at discharge Proportion of patients with beta-blocker prescribed at discharge Proportion of patients with statin prescribed at discharge Proportion of left ventricular systolic dysfunction patients with ACEI or ARB prescribed at discharge Proportion of patients received evaluation of left ventricular systolic function Proportion of patients with a diagnosed non-obstructive coronary artery disease at discharge